ResMed completes acquisition of HB Healthcare

Korea |  News | 0 Comment | 14 Mar, 2019

ResMed, a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, has announced that is has completed the acquisition of HB Healthcare (HBH) to help ...Read more

Medical Korea 2019 to explore global healthcare era

Korea |  News | 0 Comment | 06 Mar, 2019

The global healthcare and medical tourism conference "Medical Korea 2019" will be held for three days from March 14 at Grand InterContinental Seoul Parnas. This annual conference is hosted ...Read more

Can-Fite expands its Namodenoson Distribution Deal with CKD

Korea |  News | 0 Comment | 27 Feb, 2019

Can-Fite BioPharma, a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases has announced the expansion of its ...Read more

ABL Bio, WuXi Bio expand strategic collaboration for $220M

Korea |  News | 0 Comment | 26 Feb, 2019

WuXi Biologics a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and ABL Bio Corporati...Read more

Xynomic Pharma doses first South Korean patient in Phase 3 RCC trial

Korea |  News | 0 Comment | 25 Feb, 2019

Xynomic Pharma, a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corp.jointly announced the dosing of the first South Korean patient at the Asan Me...Read more

Enzychem Lifesciences completes Stage 1 patient enrollment in Ph2 CRIOM study

Korea |  News | 0 Comment | 22 Feb, 2019

Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing new drugs and APIs (Active Pharmaceutical Ingredients) has announced...Read more

Korean govt to inject $2.6B to develop biotech in 2019

Korea |  News | 0 Comment | 20 Feb, 2019

According to reports from the Korean Herald,  the government of Korea will spend 2.93 trillion won (US$2.61 billion) this year to develop new biotechnology, as part of efforts to becom...Read more

ROKIT brings innovative 3D bioprinting strategy for skin regeneration

Korea |  News | 0 Comment | 20 Feb, 2019

ROKIT Healthcare, Inc., a regenerative medicine company focused on the development of novel regenerative therapeutic strategies using three-dimensional (3D) biofabrication technologies for ...Read more

SK Biopharma to take antiepileptic drug to Europe

Korea |  News | 0 Comment | 18 Feb, 2019

SK Biopharmaceuticals and Arvelle Therapeutics GmbH have announced that they have entered into an exclusive licensing agreement for Arvelle to develop and commercialize cenobamate in Europe...Read more

Bridge Bio presents Preclinical, Ph I study results for BBT-401

Korea |  News | 0 Comment | 12 Feb, 2019

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company presented the preclinical and the Phase I study results for ...Read more

OliX announces clinical candidate for Geographic Atrophy treatment

Korea |  News | 0 Comment | 29 Jan, 2019

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clinical candidate for the treatment of Geographic Atrophy (GA), which is...Read more

US FDA approves Samsung Bioepis' first oncology drug

Korea |  News | 0 Comment | 21 Jan, 2019

Samsung Bioepis has announced that the U.S. Food and Drug Administration has approved ONTRUZANT, a biosimilar referencing HERCEPTIN (trastuzumab), across all eligible indications, name...Read more

Bridge Bio receives FDA ODD for IPF drug

Korea |  News | 0 Comment | 17 Jan, 2019

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant company of JLABS@TMC in Houston, Texas, announced that the U.S. Food and Dr...Read more

Glenmark enters commercialization agreement with Yuhan Corp

Korea |  News | 0 Comment | 10 Jan, 2019

Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, has announced that its Suisse subsidiary, Glenmark Specialty S.A., has entered into an exclusive lice...Read more

Norgine, Korea Pharma ink deal to commercialise PLENVU in Korea

Korea |  News | 0 Comment | 08 Jan, 2019

NORGINE B.V. (Norgine), a leading European specialty pharmaceutical company and KOREA PHARMA CO., LTD. (Korea Pharma), a premier pharmaceutical manufacturer in Korea, today announced an exc...Read more

Gilead Sciences, Yuhan to treat advanced fibrosis due to NASH

Korea |  News | 0 Comment | 07 Jan, 2019

Gilead Sciences, Inc. and Yuhan Corporation has announced that the companies have entered into a licensing and collaboration agreement to co-develop novel therapeutic candidates for the tre...Read more

South Korea IVD Market 2017-2022; overview by ResearchAndMarkets

Korea |  News | 0 Comment | 02 Jan, 2019

South Korea is the 27th largest country worldwide with 51.2 million people as of 2017. In their healthcare market, there is a growing demand for new technologies in the laboratory sect...Read more

Bridge Bio announces activation of clinical trial sites for Phase 2 study of UC drug candidate

Korea |  News | 0 Comment | 28 Dec, 2018

Bridge Biotherapeutics Inc, a clinical stage biotech company headquartered in Seongnam, South Korea has announced that the company has successfully activated clinical study sites for the Ph...Read more